Capricor Therapeutics · San Diego, CA · Posted 2026-11-06
Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We a…
Apply on the company siteTailor my resume for this jobFree 5-day trial — sign up with your email to apply. Mahatrix Technologies does not charge any percentage of your salary.